Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin51.9%0.0pp51.9%-0.4pp52.3%-0.6pp52.8%-0.7pp53.5%-0.2pp
Net margin6.5%-22.9pp29.4%+55.8pp-26.4%-38.9pp12.5%+97.7pp-85.2%-13.3pp
Returns
Return on equity2.5%-8.3pp10.8%+20.3pp-9.5%-14.1pp4.6%+32.1pp-27.5%-3.4pp
Return on invested capital11.4%+0.7pp10.7%+7.9pp2.8%+0.8pp2%-0.8pp2.8%-0.3pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.2×0.0×
Liquidity
Current ratio3.2×-2.4×5.6×+0.2×5.4×+0.3×5.1×-0.9×-0.5×
Leverage
Debt-to-equity0.1×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×
Per Share
Book value per share$254.15-7.0%$273.22+9.2%$250.22-4.4%$261.82+9.6%$238.93+2.6%
Valuation
Market capitalization$7.52B-7.9%$8.17B+7.7%$7.59B+17.2%$6.47B-5.1%$6.82B-25.8%
Price / sales2.9×-0.3×3.2×+0.2×+0.4×2.5×-0.2×2.7×-0.9×
Price / book1.1×0.0×1.1×0.0×1.1×+0.2×0.9×-0.1×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bio-Rad Laboratories, Inc.'s profit margins?
Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.
Where do Bio-Rad Laboratories, Inc.'s ratios come from?
Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.